Rohto Pharmaceutical Co.L... (RPHCF)

AI Score

Unlock

20.09

-6.54 (-24.56%)

At close: Jan 24, 2025, 8:00 PM

Rohto Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	89.21B	584.78M	582.48M	472.9M	413.74M	337.4M	282.68M	210.59M	200.14M
Short-Term Investments	n/a	17.01M	15.49M	6.42M	5.95M	4.62M	4.41M	4.11M	5.14M
Long-Term Investments	n/a	253.19M	231.1M	267.76M	224.65M	262.47M	307.95M	255.06M	198.31M
Other Long-Term Assets	49.72B	-9.45B	-9.42B	-7.81B	-5.06B	-3.51B	-4.05B	-2.62B	-3.45B
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	46.66B	309.07M	275.42M	252.71M	289.22M	273.39M	246.62M	211.87M	204.95M
Other Current Assets	78.89B	69.23B	57.99B	52.18B	54.18B	48.29B	53.29B	53.41B	55.64B
Total Current Assets	214.76B	1.43B	1.35B	1.2B	1.21B	1.05B	1.03B	905.93M	905.31M
Property-Plant & Equipment	68.61B	498.15M	516.22M	450.59M	449.62M	428.43M	443.75M	411.33M	427.42M
Goodwill & Intangibles	9.22B	9.56B	9.54B	7.89B	5.13B	3.56B	4.11B	2.66B	3.5B
Total Long-Term Assets	131.41B	898.96M	908.33M	842.33M	786.79M	763.89M	828.55M	723.28M	692.39M
Total Assets	346.18B	2.33B	2.26B	2.05B	2B	1.82B	1.86B	1.63B	1.6B
Account Payables	16.99B	16.02B	13.66B	9.6B	11.32B	11.01B	12.1B	9.59B	9.8B
Deferred Revenue	n/a	38M	25.11M	44.78M	42.19M	32.05M	35.98M	24.17M	34.58M
Short-Term Debt	5.3B	4.18B	8.03B	2.31B	2.1B	3.75B	4.15B	3.35B	4.45B
Other Current Liabilities	58.15B	-25.83B	-24.29B	38.42B	-18.58B	41.86B	40.63B	37.47B	-17.72B
Total Current Liabilities	87.09B	603.38M	587.27M	511.05M	575.4M	548.95M	576.7M	479.42M	528.11M
Long-Term Debt	5.19B	7.52B	13.35B	5.79B	5.19B	1.42B	1.7B	1.76B	994M
Other Long-Term Liabilities	2.68B	-8.58B	-14.73B	-6.67B	-5.78B	-1.61B	-2.61B	-4.17B	-3.21B
Total Long-Term Liabilities	12.05B	108.64M	159.3M	118.23M	124.98M	72.3M	78.9M	87.26M	79.59M
Total Liabilities	99.14B	712.02M	746.57M	629.28M	700.38M	621.24M	655.6M	566.68M	607.7M
Total Debt	10.49B	102.46M	178.44M	76.81M	71.74M	47.56M	56M	71.01M	72.98M
Common Stock	6.5B	48.96M	53.43M	58.86M	60.25M	58.24M	60.32M	57.57M	57.04M
Retained Earnings	209.4B	1.39B	1.33B	1.32B	1.22B	1.08B	1.06B	953.98M	877.96M
Comprehensive Income	n/a	140.79M	71.76M	28.66M	611.37K	37.65M	73.05M	40.25M	46.17M
Shareholders Equity	246.32B	1.58B	1.47B	1.41B	1.29B	1.19B	1.2B	1.06B	985.89M
Total Investments	44.34B	270.2M	246.6M	274.17M	230.6M	267.09M	312.36M	259.17M	203.45M